Grant: Collaborative Research and Development Grants
University of Toronto
$84,833.00
Development of a photothermal non-invasive in-vehicle alcohol detection biosensor
FY 2015-16
Summary
The development and application of a mid-infrared (MIR) two-wavelength laser-based biosensor (named Wavelength-Modulated Differential Photothermal Radiometry, WM-DPTR) is proposed as a fast, noninvasive all optical blood alcohol diagnostic monitor for use in the fight against drunk driving in Canada and potentially world-wide, in collaboration with our industrial partner, Alcohol Countermeasure Systems (ACS), Etobicoke, ON. Our previous research using a skin-glucose-blood serum phantom diffused into skin demonstrated that WM-DPTR has the highest sensitivity to glucose amongst noninvasive techniques to-date. Preliminary testing of WM-DPTR with a similar skin-ethanol-blood serum phantom configuration showed that similar performance should be expected in the case of ethanol. Project goal is to develop a laboratory prototype of an in-vehicle WM-DPTR alcohol interlock system. A major part of this CRD Proposal is to replace the commercial two-quantum cascade laser (QCL)-module in the biosensor with one-laser-module for substantial price decrease at commercial-level (~ 500) quantities. ACS is also collaborating with the University of Waterloo for the development of inexpensive (~$500) and compact mid-IR lasers for supporting the commercialization of WM-DPTR technology.
Specific goals of the proposed research are A) to perform detailed quantitative studies of the sensitivity and specificity of the biosensor-to-be-assembled to the presence of ethyl alcohol in water and blood serum solutions, as well as with ethanol diffused in human skin samples simulating interstitial fluid detection, in the range of human blood alcohol concentration (0 - 200 mg/dl); B) to simplify sensor design by replacing two QCL lasers with one; and C) to test the biosensor on human volunteers. The dimensions of the proposed portable pre-prototype system will be: a handheld probe 6""x2""x2"" which includes the laser head, the MIR detector and optics; and an electrical control unit (ECU) 6""x6""x2"" under the vehicle dashboard. These dimensions are compatible with current ACS in-vehicle electrochemical sensor interlocks.
Program
Collaborative Research and Development Grants
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
476390-2014
Name nom
Mandelis, Andreas
Department département
Mechanical and Industrial Engineering
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2014
Award amount
84833
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
1
Nb partie
2
Application title
Development of a photothermal non-invasive in-vehicle alcohol detection biosensor
Keyword
NSERC
Application summary
The development and application of a mid-infrared (MIR) two-wavelength laser-based biosensor (named Wavelength-Modulated Differential Photothermal Radiometry, WM-DPTR) is proposed as a fast, noninvasive all optical blood alcohol diagnostic monitor for use in the fight against drunk driving in Canada and potentially world-wide, in collaboration with our industrial partner, Alcohol Countermeasure Systems (ACS), Etobicoke, ON. Our previous research using a skin-glucose-blood serum phantom diffused into skin demonstrated that WM-DPTR has the highest sensitivity to glucose amongst noninvasive techniques to-date. Preliminary testing of WM-DPTR with a similar skin-ethanol-blood serum phantom configuration showed that similar performance should be expected in the case of ethanol. Project goal is to develop a laboratory prototype of an in-vehicle WM-DPTR alcohol interlock system. A major part of this CRD Proposal is to replace the commercial two-quantum cascade laser (QCL)-module in the biosensor with one-laser-module for substantial price decrease at commercial-level (~ 500) quantities. ACS is also collaborating with the University of Waterloo for the development of inexpensive (~$500) and compact mid-IR lasers for supporting the commercialization of WM-DPTR technology.
Specific goals of the proposed research are A) to perform detailed quantitative studies of the sensitivity and specificity of the biosensor-to-be-assembled to the presence of ethyl alcohol in water and blood serum solutions, as well as with ethanol diffused in human skin samples simulating interstitial fluid detection, in the range of human blood alcohol concentration (0 - 200 mg/dl); B) to simplify sensor design by replacing two QCL lasers with one; and C) to test the biosensor on human volunteers. The dimensions of the proposed portable pre-prototype system will be: a handheld probe 6""x2""x2"" which includes the laser head, the MIR detector and optics; and an electrical control unit (ECU) 6""x6""x2"" under the vehicle dashboard. These dimensions are compatible with current ACS in-vehicle electrochemical sensor interlocks.